Katharina C. Kähler

Baseline Biomarkers for Outcome of Melanoma Patients Treated with Pembrolizumab

Benjamin Weide, Alexander Martens, Jessica C. Hassel et al. · Clinical Cancer Research · 2016 · 584 citations · Full text

Medicine, Clinical Sciences, Oncology +17

Myositis and neuromuscular side-effects induced by immune checkpoint inhibitors

Alvaro Moreira, Carmen Loquai, Claudia Pföhler et al. · European Journal of Cancer · 2018 · 235 citations

Life Sciences, Immunology, Pharmacotherapy +14

Programmed cell death protein-1 (PD-1) inhibitor therapy in patients with advanced melanoma and preexisting autoimmunity or ipilimumab-triggered autoimmunity

Ralf Gutzmer, Anika Koop, Friedegund Meier et al. · European Journal of Cancer · 2017 · 218 citations

Life Sciences, Immunology, Oncology +17

Systematic outperformance of 112 dermatologists in multiclass skin cancer image classification by convolutional neural networks

Roman C. Maron, Michael Weichenthal, Jochen Utikal et al. · European Journal of Cancer · 2019 · 218 citations · Full text

Medicine, Dermatology, Oncology +15

Prognostic factors and outcomes in metastatic uveal melanoma treated with programmed cell death-1 or combined PD-1/cytotoxic T-lymphocyte antigen-4 inhibition

Markus V. Heppt, Lucie Heinzerling, Katharina C. Kähler et al. · European Journal of Cancer · 2017 · 203 citations

Medicine, Immunology, Oncology +17